Impact of Resveratrol and Pharmaceutical Care on Type 2 Diabetes Mellitus and Its Neuropathic Complication: A Randomized Placebo Controlled Clinical Trial

Figure 1

Flowchart for participant’s enrollment, interventions, and outcome measures. n, number of patients; HA, hypoglycemic agent; PC, pharmaceutical care; Resv, resveratrol; DTP, drug therapy problem; MNSI, Michigan Neuropathy Screening Instrument for neuropathic signs and symptoms; DN4, Douleur Neuropathique 4 questions for neuropathic signs and symptoms; VAS, visual analogue scale for the severity of pain.